Evaluation of Lofexidine for Treatment of Opiate Withdrawal - 10



Status:Completed
Conditions:Gastrointestinal
Therapuetic Areas:Gastroenterology
Healthy:No
Age Range:21 - 50
Updated:1/13/2017
Start Date:April 1996

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Evaluation of Lofexidine for Treatment of Opiate Withdrawal

The purpose of this study is to assess the safety of lofexidine in the treatment of
opiate-dependent individuals.


Inclusion Criteria:

M/F ages 21-50. Meet DSM-IV criteria for opiate dependence. Agree to conditions of the
study and sign informed consent.

Exclusion Criteria:

Psychiatric disorder that requires medication therapy. History of seizures. Pregnant
and/or nuring women. Dependence on ETOH or benzodiazepines or other sedative/hypnotics.
Acute hepatitis. Other medical condtions that deem participation to be unsafe.
We found this trial at
1
site
Friends Research Institute
Los Angeles, California 90025
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials